PatientsVille.com Logo

PatientsVille

Betamethasone Side Effects

Common Betamethasone Side Effects


The most commonly reported Betamethasone side effects (click to view or check a box to report):

Erythema (26)
Condition Aggravated (24)
Malaise (19)
Pyrexia (18)
Dyspnoea (18)
Exposure During Pregnancy (17)
Caesarean Section (16)
Anaphylactic Shock (15)
Nausea (14)
Premature Baby (13)
Injection Site Pain (13)
Stevens-johnson Syndrome (12)
Fall (12)
Injection Site Erythema (12)
Pruritus (12)
Hepatic Function Abnormal (11)
Hyperglycaemia (11)
Toxic Anterior Segment Syndrome (11)
Maternal Exposure During Pregnancy (11)
Hyperhidrosis (11)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Betamethasone Side Effects Reported to FDA

The following Betamethasone reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Betamethasone on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Exposure During Pregnancy
This is a report of a 40-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Betamethasone Dipropionate (dosage: Unk, start time: 201402), combined with:
  • Magnesium Sulfate (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Exposure During Pregnancy
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Betamethasone Dipropionate treatment in female patients, resulting in exposure during pregnancy side effect.

Hiccups, Dyspnoea, Cough, Respiratory Distress, Respiratory Failure, Pneumonia, Respiratory Arrest, Hyponatraemia, Unevaluable Event
This report suggests a potential Betamethasone Sodium Phosphate Hiccups, Dyspnoea, Cough, Respiratory Distress, Respiratory Failure, Pneumonia, Respiratory Arrest, Hyponatraemia, Unevaluable Event side effect(s) that can have serious consequences. A 85-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Betamethasone Sodium Phosphate (dosage: NA) starting Jan 06, 2014. Soon after starting Betamethasone Sodium Phosphate the patient began experiencing various side effects, including:
  • Hiccups
  • Dyspnoea
  • Cough
  • Respiratory Distress
  • Respiratory Failure
  • Pneumonia
  • Respiratory Arrest
  • Hyponatraemia
  • Unevaluable Event
Drugs used concurrently: NA.The patient was hospitalized. Although Betamethasone Sodium Phosphate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hiccups, may still occur.

Product Colour Issue, Product Odour Abnormal, Product Substitution Issue
This Product Colour Issue, Product Odour Abnormal, Product Substitution Issue problem was reported by a consumer or non-health professional from US. A 70-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: rash pruritic. On Feb 28, 2014 this consumer started treatment with Betamethasone Dipropionate (dosage: As Needed As Needed Applied To A Surface, Usually The Skin). The following drugs were being taken at the same time: NA. When commencing Betamethasone Dipropionate, the patient experienced the following unwanted symptoms/side effects:
  • Product Colour Issue
  • Product Odour Abnormal
  • Product Substitution Issue
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as product colour issue, may become evident only after a product is in use by the general population.

Optic Neuritis
This is a report of a 12-year-old male patient (weight: NA) from IN. The patient developed the following symptoms/conditions: uveitis and was treated with Betamethasone (dosage: NA) starting NS. Concurrently used drugs:
  • Homatropine
Soon after that, the consumer experienced the following side effects:
  • Optic Neuritis
This opens a possibility that Betamethasone treatment could cause the above reactions, including optic neuritis, and some male subjects may be more susceptible.


Glaucoma, Intraocular Pressure Test
A 13-year-old male patient (weight: NA) from TW with the following symptoms/conditions: keratitis started Betamethasone treatment (dosage: Unk) on NS. Soon after starting Betamethasone treatment, the subject experienced various side effects, including:
  • Glaucoma
  • Intraocular Pressure Test
Concurrently used drugs:
  • Cromlyn
  • Cetirizine
This finding indicates that some male patients could be more vulnerable to Betamethasone.

Localised Oedema, Tongue Oedema, Erythema, Angioedema
A 64-year-old male patient from IT (weight: NA) experienced symptoms, such as: tongue oedema and was treated with Betamethasone(dosage: 2mg X Os). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Localised Oedema
  • Tongue Oedema
  • Erythema
  • Angioedema
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Betamethasone efficacy:
  • Lisinopril (5mg/day)
  • Atenolol (100mg/day)


Glaucoma
In this report, Betamethasone Sodium Phosphate was administered for the following condition: NA.A 25-year-old female consumer from JP (weight: NA) started Betamethasone Sodium Phosphate treatment (dosage: Duration 4 Months) on 200705.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Glaucoma
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Betamethasone Sodium Phosphate treatment could be related to the listed above side effect(s).

Inappropriate Antidiuretic Hormone Secretion
This is a report of the following Betamethasone Sodium Phosphate side effect(s):
  • Inappropriate Antidiuretic Hormone Secretion
A 81-year-old female patient from JP (weight: NA) presented with the following condition: cachexia,depression,insomnia and received a treatment with Betamethasone Sodium Phosphate (dosage: 4 Mg, Twice Daily) starting: Jul 04, 2013.The following concurrently used drugs could have generated interactions:
  • Cymbalta (20 Mg Daily Dose)
  • Lendormin (0.25mg Daily Dose)
  • Rozerem (8mg Daily Dose)
  • Sairei-to (12g Daily Dose)
  • Depas (0.5 Mg Daily Dose)
This report suggests that a Betamethasone Sodium Phosphate treatment could be associated with the listed above side effect(s).

Exposure During Pregnancy
This Betamethasone report was submitted by a 27-year-old female consumer from US (weight: NA). The patient was diagnosed with: NA and Betamethasone was administered (dosage: Unk) starting: NS. The consumer developed a set of symptoms:
  • Exposure During Pregnancy
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Betamethasone treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Chest Pain, Formication, Pruritus, Erythema
This is a report of a possible correlation between Betamethasone Dipropionate\gentamicin Sulfate use and the following symptoms/side effect(s):
  • Chest Pain
  • Formication
  • Pruritus
  • Erythema
which could contribute to an assessment of Betamethasone Dipropionate\gentamicin Sulfate risk profile.A 41-year-old female consumer from ES (weight: NA) was suffering from skin bacterial infection and was treated with Betamethasone Dipropionate\gentamicin Sulfate (dosage: NA) starting Sep 18, 2013.Other concurrent medications:
  • Ciprofloxacin (500 Mg, Bid)


Pulmonary Oedema, Endotracheal Intubation, Exposure During Pregnancy
A 39-year-old female patient from TR (weight: NA) presented with the following symptoms: NA and after a treatment with Betamethasone Dipropionate (dosage: 12 Mg, Qd) experienced the following side effect(s):
  • Pulmonary Oedema
  • Endotracheal Intubation
  • Exposure During Pregnancy
The treatment was started on NS. Betamethasone Dipropionate was used in combination with the following drugs:
  • Nifedipine (40 Mg, Every 6 Hours)
  • Amoxicillin (1 G, Qid)
The patient was hospitalized.This report could alert potential Betamethasone Dipropionate consumers.

Necrotising Fasciitis
In this report, a 55-year-old male patient from PT (weight: NA) was affected by a possible Betamethasone side effect.The patient was diagnosed with NA. After a treatment with Betamethasone (dosage: 14mg/2ml, start date: NS), the patient experienced the following side effect(s):
  • Necrotising Fasciitis
The following simultaneously used drugs could have led to this reaction:
  • Xylocaine
  • Physiologica Gifrer
  • Metformin
  • Insulin
The patient was hospitalized and became disabled.The findings here stress that side effects should be taken into consideration when evaluating a Betamethasone treatment.

Adverse Event
This is a report of a 65-year-old female patient from US (weight: NA), who used Betamethasone Dipropionate (dosage: Unk) for a treatment of eczema. After starting a treatment on 200310, the patient experienced the following side effect(s):
  • Adverse Event
The following drugs could possibly have interacted with the Betamethasone Dipropionate treatment NA.Taken together, these observations suggest that a Betamethasone Dipropionate treatment could be related to side effect(s), such as Adverse Event.

Hepatic Function Abnormal
This hepatic function abnormal side effect was reported by a consumer or non-health professional from JP. A 63-year-old female patient (weight:NA) experienced the following symptoms/conditions: lung neoplasm malignant,metastases to bone. The patient was prescribed Betamethasone Sodium Phosphate (dosage: 4 Mg, Qd, (route Of Administration : Dr)), which was started on Jun 04, 2013. Concurrently used drugs: NA. When starting to take Betamethasone Sodium Phosphate the consumer reported the following symptoms:
  • Hepatic Function Abnormal
These side effects may potentially be related to Betamethasone Sodium Phosphate.

Rash
This is a Betamethasone Dipropionate side effect report of a 72-year-old female patient (weight:NA) from COUNTRY NOT SPECIFIED, suffering from the following symptoms/conditions: eczema, who was treated with Betamethasone Dipropionate (dosage:NA, start time: 201302), combined with: NA., and developed a serious reaction and a rash side effect. The patient presented with:
  • Rash
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Betamethasone Dipropionate treatment in female patients suffering from eczema, resulting in rash.

Therapeutic Response Decreased, Incorrect Product Storage
This report suggests a potential Betamethasone Dipropionate therapeutic response decreased side effect(s) that can have serious consequences. A 60-year-old female patient from COUNTRY NOT SPECIFIED (weight:NA) was diagnosed with the following health condition(s): NA and used Betamethasone Dipropionate (dosage: NA) starting Sep 28, 2012. Soon after starting Betamethasone Dipropionate the patient began experiencing various side effects, including:
  • Therapeutic Response Decreased
  • Incorrect Product Storage
Drugs used concurrently:NA. Although Betamethasone Dipropionate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as therapeutic response decreased, may still occur.

Alopecia Areata, Condition Aggravated, Application Site Erythema, Application Site Pain, Off Label Use
This alopecia areata problem was reported by a consumer or non-health professional from US. A female patient (weight: NA) was diagnosed with the following medical condition(s): alopecia areata,vitamin supplementation.On 201305 a consumer started treatment with Betamethasone Dipropionate (dosage: NA). The following drugs/medications were being taken at the same time:
  • Multivitamin
  • Vitamin B Complex
  • Vitamin D
When commencing Betamethasone Dipropionate, the patient experienced the following unwanted symptoms /side effects:
  • Alopecia Areata
  • Condition Aggravated
  • Application Site Erythema
  • Application Site Pain
  • Off Label Use
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as alopecia areata, may become evident only after a product is in use by the general population.

Exposure During Pregnancy
This is a Betamethasone side effect report of a 35-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: foetal growth restriction,convulsion prophylaxis and was treated with Betamethasone (dosage: NA) starting NS. Concurrently used drugs:
  • Magnesium Sulfate
Soon after that, the consumer experienced the following of symptoms:
  • Exposure During Pregnancy
This opens a possibility that Betamethasone could cause exposure during pregnancy and that some female patients may be more susceptible.

Exposure During Pregnancy
A 39-year-old female patient (weight: NA) from US with the following symptoms: NA started Betamethasone treatment (dosage: First Full Course) on NS. Soon after starting Betamethasone treatment, the consumer experienced several side effects, including:
  • Exposure During Pregnancy
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Betamethasone side effects, such as exposure during pregnancy.

Exposure During Pregnancy
This exposure during pregnancy side effect was reported by a health professional from US. A 30-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Betamethasone (dosage: Two Doses), which was started on NS. Concurrently used drugs: NA..When starting to take Betamethasone the consumer reported symptoms, such as:
  • Exposure During Pregnancy
These side effects may potentially be related to Betamethasone.

Exposure During Pregnancy
This is a report of a 27-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Betamethasone (dosage: 12 Mg, Every 24 Hours For 2 Doses, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Exposure During Pregnancy
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Betamethasone treatment in female patients, resulting in exposure during pregnancy side effect.

Exposure During Pregnancy
This report suggests a potential Betamethasone Exposure During Pregnancy side effect(s) that can have serious consequences. A 16-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Betamethasone (dosage: Course Of 2 Doses) starting NS. Soon after starting Betamethasone the patient began experiencing various side effects, including:
  • Exposure During Pregnancy
Drugs used concurrently: NA. Although Betamethasone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as exposure during pregnancy, may still occur.

Product Substitution Issue, Product Quality Issue
This Product Substitution Issue, Product Quality Issue problem was reported by a consumer or non-health professional from US. A 52-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: psoriasis. On Jul 24, 2013 this consumer started treatment with Betamethasone Valerate (dosage: Twice Daily Applied To A Surface Usually The Skin.). The following drugs were being taken at the same time: NA. When commencing Betamethasone Valerate, the patient experienced the following unwanted symptoms/side effects:
  • Product Substitution Issue
  • Product Quality Issue
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as product substitution issue, may become evident only after a product is in use by the general population.

Exposure During Pregnancy
This is a report of a 35-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Betamethasone (dosage: Unk) starting NS. Concurrently used drugs:
  • Magnesium Sulfate
Soon after that, the consumer experienced the following side effects:
  • Exposure During Pregnancy
This opens a possibility that Betamethasone treatment could cause the above reactions, including exposure during pregnancy, and some female subjects may be more susceptible.

Paraparesis
A 48-year-old male patient (weight: NA) from US with the following symptoms/conditions: intervertebral disc protrusion,lumbar radiculopathy started Betamethasone Dipropionate treatment (dosage: 2 Ml, Unk) on NS. Soon after starting Betamethasone Dipropionate treatment, the subject experienced various side effects, including:
  • Paraparesis
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Betamethasone Dipropionate.

1 of 22 



Top 10 Betamethasone Side Effects for Men

Men Side EffectsReports
Dyspnoea 10
Fall 10
Hypertension 10
Pyrexia 10
Erythema 9
Condition Aggravated 8
Insomnia 8
Haemorrhagic Stroke 7
Malaise 7
Pneumonia 7

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Betamethasone Side Effects

    Did You Have a Betamethasone Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Betamethasone for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Betamethasone Safety Alerts, Active Ingredients, Usage Information

    NDC0115-1472
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameBetamethasone
    NameBetamethasone
    Dosage FormCREAM
    RouteTOPICAL
    On market since20040123
    LabelerGlobal Pharmaceuticals, Division of Impax Laboratories Inc.
    Active Ingredient(s)BETAMETHASONE DIPROPIONATE
    Strength(s)0.5
    Unit(s)mg/g
    Pharma ClassCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

    More About Betamethasone

    Side Effects reported to FDA: 527

    Betamethasone safety alerts: No

    Reported deaths: 39

    Reported hospitalizations: 153

    Latest Betamethasone clinical trials